Insulin Lispro NDC 50090-5391

Product information

Brand name (proprietary)

Insulin Lispro

Generic name (nonproprietary)

insulin lispro

Active ingredients

Insulin lispro — 100 [iU]/mL

Dosage form

Injection, Solution

Route

Intravenous, Subcutaneous

Labeler

A-S Medication Solutions

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 020563

Marketing start

Feb 12, 2020

Listing expires

Dec 31, 2027

Other FDA classes

Insulin (Chemical/Ingredient)

Identifiers

Product ID 50090-5391_ef0bf54c-1dc8-44d5-b00d-9d0f6c769db5SPL ID ef0bf54c-1dc8-44d5-b00d-9d0f6c769db5

Pharmacologic class

Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N450090539100 followed by a unit qualifier and the quantity Copy

Package 50090-5391-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 020563

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.